Balyasny Asset Management »

Milestone Pharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Milestone Pharmaceuticals (MIST) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Milestone Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Milestone Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Milestone Pharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 851k 1.19

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Milestone Pharmaceuticals

Propel Bio Management
Adage Capital Partners GP
Rtw Investments
Two Sigma Investments
Goldman Sachs Group
Marshall Wace
Millennium Management
Simplify Asset Management
Susquehanna International
Point72 Asset Management
Balyasny Asset Management
Lion Point Capital
Toronto-Dominion Bank
Morgan Stanley
Boxer Capital Management

View all funds holding Milestone Pharmaceuticals